Evidence map›Paper›PMID 21852229›Full record

ArticleThe Journal of biological chemistry2011

Raptor and Rheb negatively regulate skeletal myogenesis through suppression of insulin receptor substrate 1 (IRS1).

Yejing Ge, Mee-Sup Yoon, Jie Chen

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. A non-translational role of threonyl-tRNA synthetase in regulating JNK signaling during myogenic differentiation.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Effects of rapamycin on growth hormone receptor knockout mice.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. XPLN is an endogenous inhibitor of mTORC2.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Yejing GeDepartment of Cell and Developmental Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801.
Mee-Sup YoonDepartment of Cell and Developmental Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801.
Jie ChenDepartment of Cell and Developmental Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801. Electronic address: jiechen@illinois.edu.
University of Illinois Urbana-Champaign · US

Funding

mTOR Signaling in Skeletal MyogenesisR01AR048914 · NIAMS · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI CHEN, JIE · 2003 to 2019
$4.8M
Phospholipase D signalingR01GM089771 · NIGMS · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI CHEN, JIE · 2011 to 2025
$3.9M
Signaling mechanisms in muscle regenerationR56AR048914 · NIAMS · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI CHEN, JIE · 2021 to 2021
$373k
NIAMS NIH HHS AR048914NIAMS NIH HHS R01 AR048914NIAMS NIH HHS R56 AR048914NIGMS NIH HHS R01 GM089771
6 · The paper itself

Abstract

The mammalian target of rapamycin (mTOR) is essential for skeletal myogenesis through controlling distinct cellular pathways. The importance of the canonical mTOR complex 1 signaling components, including raptor, S6K1, and Rheb, had been suggested in muscle maintenance, growth, and metabolism. However, the role of those components in myogenic differentiation is not entirely clear. In this study we have investigated the functions of raptor, S6K1, and Rheb in the differentiation of C2C12 mouse myoblasts. We find that although mTOR knockdown severely impairs myogenic differentiation as expected, the knockdown of raptor, as well as Rheb, enhances differentiation. Consistent with a negative role for these proteins in myogenesis, overexpression of raptor or Rheb inhibits C2C12 differentiation. On the other hand, neither knockdown nor overexpression of S6K1 has any effect. Moreover, the enhanced differentiation elicited by raptor or Rheb knockdown is accompanied by increased Akt activation, elevated IRS1 protein levels, and decreased Ser-307 (human Ser-312) phosphorylation on IRS1. Finally, IRS1 knockdown eliminated the enhancement in differentiation elicited by raptor or Rheb knockdown, suggesting that IRS1 is a critical mediator of the myogenic functions of raptor and Rheb. In conclusion, the Rheb-mTOR/raptor pathway negatively regulates myogenic differentiation by suppressing IRS1-PI3K-Akt signaling. These findings underscore the versatility of mTOR signaling in biological regulations and implicate the existence of novel mTOR complexes and/or signaling mechanism in skeletal myogenesis.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsCarrier ProteinsCell DifferentiationCell LineGene Knockdown TechniquesHumansInsulin Receptor Substrate ProteinsMiceMonomeric GTP-Binding ProteinsMuscle DevelopmentMuscle, SkeletalMyoblasts, SkeletalNeuropeptidesPhosphatidylinositol 3-KinasesPhosphorylationAdaptor Proteins, Signal TransducingCarrier ProteinsInsulin Receptor Substrate ProteinsIrs1 protein, mouseMonomeric GTP-Binding ProteinsmTOR protein, mouseNeuropeptidesPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktRas Homolog Enriched in Brain ProteinRegulatory-Associated Protein of mTORRheb protein, mouseRibosomal Protein S6 Kinases, 90-kDaRps6ka1 protein, mouseRptor protein, mouseTOR Serine-Threonine Kinases

Identifiers

PMID21852229
PMCPMC3195566
OpenAlexW2053635573

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.